<!DOCTYPE html>
<html lang="en">

<head>

  <meta charset="utf-8">
  <meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no">
  <meta name="description" content="">
  <meta name="author" content="">

<title>PROGRAM - SIG: DRUG-DESIGN</title>

  <!-- Bootstrap core CSS -->
  <link href="vendor/bootstrap/css/bootstrap.min.css" rel="stylesheet">

  <!-- Custom fonts for this template -->
  <link href="https://fonts.googleapis.com/css?family=Raleway:100,100i,200,200i,300,300i,400,400i,500,500i,600,600i,700,700i,800,800i,900,900i" rel="stylesheet">
  <link href="https://fonts.googleapis.com/css?family=Lora:400,400i,700,700i" rel="stylesheet">

  <!-- Custom styles for this template -->
  <link href="css/business-casual.css" rel="stylesheet">

</head>

<body>

  <h1 class="site-heading text-center text-white d-none d-lg-block">
    <span class="site-heading-upper text-primary mb-3">Special Interest Group</span>
    <span class="site-heading-lower">DRUG-DESIGN</span>
  </h1>

  <!-- Navigation -->
  <nav class="navbar navbar-expand-lg navbar-dark py-lg-4" id="mainNav">
    <div class="container">
      <a class="navbar-brand text-uppercase text-expanded font-weight-bold d-lg-none" href="#">SIG: DRUG-DESIGN</a>
      <button class="navbar-toggler" type="button" data-toggle="collapse" data-target="#navbarResponsive" aria-controls="navbarResponsive" aria-expanded="false" aria-label="Toggle navigation">
        <span class="navbar-toggler-icon"></span>
      </button>
      <div class="collapse navbar-collapse" id="navbarResponsive">
        <ul class="navbar-nav mx-auto">
          <li class="nav-item px-lg-3">
            <a class="nav-link text-uppercase text-expanded" href="index.html">Home
            </a>
          </li>
          <li class="nav-item px-lg-3">
            <a class="nav-link text-uppercase text-expanded" href="about.html">About</a>
          </li>
          <li class="nav-item px-lg-4">
                <a class="nav-link text-uppercase text-expanded" href="conduct.html">Code of Conduct</a>
          </li>
          <li class="nav-item active px-lg-3">
            <a class="nav-link text-uppercase text-expanded" href="program.html">Program
            <span class="sr-only">(current)</span></a>
          </li>
          <li class="nav-item px-lg-3">
                <a class="nav-link text-uppercase text-expanded" href="abstracts.html">Abstracts</a>
              </li>
          <li class="nav-item px-lg-3">
            <a class="nav-link text-uppercase text-expanded" href="registration.html">Registration</a>
          </li>
          <li class="nav-item px-lg-4">
            <a class="nav-link text-uppercase text-expanded" href="posters.html">Poster Session</a>
          </li>
		  <li class="nav-item px-lg-3">
            <a class="nav-link text-uppercase text-expanded" href="contact.html">Contact</a>
          </li>
        </ul>
      </div>
    </div>
  </nav>


  <section class="page-section cta">
		<div class="container">
			<div class="row align-items-stretch">
        <div class="col-xl-10 col-lg-10 mx-auto">
					<div id="key_dates" class="intro-text text-center bg-faded p-5 rounded ml-auto">
						<h2 class="section-heading mb-5">
							<span class="section-heading-lower">Program </span>
						</h2>
            <p class="mb-0"> BRASÍLIA TIME = GMT-3</p>
            <p></p>

        <div class="tab-content row justify-content-center" data-aos-delay="200">
			<div role="tabpanel" class="col-lg-10 tab-pane show active">

			 <div class="row schedule-item">
              <div class="col-md-2"><time>9:00 AM</time></div>
              <div class="col-md-10">
                <p style="font-size:18px">Opening Words</p>
              </div>
            </div>

			 <div class="row schedule-item">
              <div class="col-md-2"><time>09:10 AM</time></div>
              <div class="col-md-10">
                <p><b>Lightning talk 1:</b> "Virtual Screening of Substances with Potential Antiviral Activity Against Three Flaviviruses: Dengue Virus, Yellow Fever Virus and Zika Virus" by <b>Mateus Serafim</b></p>
              </div>
			 </div>

			 <div class="row schedule-item">
              <div class="col-md-2"><time>09:30 AM</time></div>
              <div class="col-md-10">
                <p><b>Lightning talk 2:</b> "Phenotypic Screening of Compounds Enriched by Molecular Docking to Protein Kinase Targets in Schistosoma Mansoni" by <b>Naiara Clemente Tavares</b></p>
              </div>
			 </div>

            <div class="row schedule-item">
              <div class="col-md-2"><time>09:50 AM</time></div>
              <div class="col-md-10">
				<p style="font-size:17px"><b>"Targeting proteases to treat neglected and emerging diseases"</b> by <b><a href="#rafaela">Rafaela Ferreira</a></b></p>
              </div>
            </div>

            <div class="row schedule-item">
              <div class="col-md-2"><time>10:40 AM</time></div>
              <div class="col-md-10">
                <p><b>Lightning Talk 3:</b> "Arg2 Snps Associated with Hbf Response in Patients Sickle Cell Anemia Treated with Hydroxyurea" by <b>Bárbara Nogueira</b></p>
              </div>
            </div>

            <div class="row schedule-item">
              <div class="col-md-2"><time>11:00 AM</time></div>
              <div class="col-md-10">
                <p> <b>Lightning Talk 4:</b>"Construction of a Nanoparticle Based on a Synthetic Virus-like Protein with Chemotherapy Potential" by <b>Amanda Patrícia Gonçalves</b></p>
              </div>
            </div>

            <div class="row schedule-item">
              <div class="col-md-2"><time>11:20 AM</time></div>
              <div class="col-md-10">
			    <p style="font-size:17px"><b>"Molecular intervention of SARS-CoV-2 drug targets as potential therapy for COVID-19"</b> by <b><a href="#neera">Neera Borkakoti</a></b></p>
              </div>
            </div>

            <div class="row schedule-item">
              <div class="col-md-2"><time>12:10 - 13:10</time></div>
              <div class="col-md-10">
                <p style="font-size:18px">Lunch Break</p>
                <p></p>
              </div>
            </div>

            <div class="row schedule-item">
              <div class="col-md-2"><time>13:10 PM</time></div>
              <div class="col-md-10">
				<p style="font-size:17px"><b>"Data fusion in drug-target interaction prediction for drug repositioning"</b> by <b><a href="#daniele">Daniele Parisi</a></b></p>
              </div>
            </div>

            <div class="row schedule-item">
              <div class="col-md-2"><time>14:00 PM</time></div>
              <div class="col-md-10">
                <p><b>Lightning talk 5:</b> "Metformin Regulates Cells Epigenomic Landscape Leading to Decreased Proliferation and Inflammation in Hepatocytes" by <b>Izabela Conceição</b></p>
              </div>
            </div>

            <div class="row schedule-item">
              <div class="col-md-2"><time>14:20 PM</time></div>
              <div class="col-md-10">
                <p><b>Lightning Talk 6: </b> "In Silico Approaches for Mycoplasma Pneumoniae Multi-Epitope Vaccine Construction" by <b>Thaís Cristina Rodrigues</b></p>
              </div>
            </div>

            <div class="row schedule-item">
              <div class="col-md-2"><time>14:40 PM</time></div>
              <div class="col-md-10">
				<p style="font-size:17px"><b>"Network Medicine approaches for the study of SARS-CoV2 and drug repurposing"</b> by <b><a href="#deisy">Deisy Morselli Gysi</a></b></p>
              </div>
            </div>

            <div class="row schedule-item">
              <div class="col-md-2"><time>15:30 PM</time></div>
              <div class="col-md-10">
                <p style="font-size:18px">Closing Words</p>
              </div>
            </div>
          </div>

			</div>
		</div>
	 </div>
	 </div>
	 </div>
	 </div>
	 </section>

  <section class="page-section cta">
    <div id="neera" class="container">
      <div class="row align-items-center">
        <div class="col-lg-4 order-lg-2">
          <div class="p-0 m-0" style="text-align:center">
            <h3 class="text-center text-white keynote">CONFIRMED SPEAKER</h3>
            <p></p>
            <a href="img/borkakoti.png" target="_blank">
            <img class="img-fluid rounded-circle" src="img/neera.jpg" alt="">
            </a>
            <p></p>
            <h5 class="text-center text-white">Neera Borkakoti</h5>
            <h6 class="text-center text-white">Wellcome Genome Campus, UK</h6>
            <h6 class="text-center text-white">Visiting Scientist - EMBL-EBI</h6>
          </div>
        </div>
        <div class="col-lg-8 order-lg-1">
          <div class="bg-faded p-4 intro-text ml-auto rounded">
            <h5 class="text-center bold"> Molecular intervention of SARS-CoV-2 drug targets as potential therapy for COVID-19</h5>
            <p></p>
            <p class="mb-3" align="justify"> The COVID-19 pandemic has highlighted the need to quickly and reliably prioritize clinically approved compounds for their potential effectiveness for SARS-CoV-2 infections. I will present here a set of deployed algorithms relying on artificial intelligence, network diffusion, and network proximity, tasking each of them to rank 6,340 drugs for their expected efficacy against SARS-CoV-2. To test the predictions, we used as ground truth 918 drugs experimentally screened in VeroE6 cells, as well as the list of drugs in clinical trials that capture the medical community’s assessment of drugs with potential COVID-19 efficacy. Even though all methods have high predictive power, the consensus of those methods increase the hit rate to 62%, in contrast to the usual 0,8% when non targeted screenings. We also find that 76 of the 77 drugs that successfully reduced viral infection in VeroE6 cells do not bind the proteins targeted by SARS-CoV-2, indicating that these drugs rely on network-based mechanisms that cannot be identified using docking-based strategies. These advances offer a novel methodological pathway to identify repurposable drugs for future pathogens and neglected diseases underserved by the costs and extended timeline of de novo drug development.
            </p>
          </div>
        </div>
      </div>
    </div>
  </section>

  <section class="page-section cta">
    <div id="deisy"class="container">
      <div class="row align-items-center">
        <div class="col-lg-4 order-lg-1">
          <div class="p-0 m-0" style="text-align:center">
            <h3 class="text-center text-white keynote">CONFIRMED SPEAKER</h3>
            <p></p>
            <a href="#">
            <img class="img-fluid rounded-circle" src="img/deisy.jpg" alt="">
            </a>
            <p></p>
            <h5 class="text-center text-white">Deisy Morselli Gysi</h5>
            <h6 class="text-center text-white">CCNR - Northeastern University, USA</h6>
            <h6 class="text-center text-white">Postdoctoral Researcher Associated</h6>
          </div>
        </div>
        <div class="col-lg-8 order-lg-2">
          <div class="bg-faded p-4 intro-text ml-auto rounded">
            <h5 class="text-center bold">Network Medicine approaches for the study of SARS-CoV2 and drug repurposing</h5>
            <p></p>
            <p class="mb-3" align="justify"> The COVID-19 pandemic has highlighted the need to quickly and reliably prioritize clinically approved compounds for their potential effectiveness for SARS-CoV-2 infections. I will present here a set of deployed algorithms relying on artificial intelligence, network diffusion, and network proximity, tasking each of them to rank 6,340 drugs for their expected efficacy against SARS-CoV-2. To test the predictions, we used as ground truth 918 drugs experimentally screened in VeroE6 cells, as well as the list of drugs in clinical trials that capture the medical community’s assessment of drugs with potential COVID-19 efficacy. Even though all methods have high predictive power, the consensus of those methods increase the hit rate to 62%, in contrast to the usual 0,8% when non targeted screenings. We also find that 76 of the 77 drugs that successfully reduced viral infection in VeroE6 cells do not bind the proteins targeted by SARS-CoV-2, indicating that these drugs rely on network-based mechanisms that cannot be identified using docking-based strategies. These advances offer a novel methodological pathway to identify repurposable drugs for future pathogens and neglected diseases underserved by the costs and extended timeline of de novo drug development.
            </p>
          </div>
        </div>
      </div>
    </div>
  </section>

  <section class="page-section cta">
    <div id="rafaela" class="container">
      <div class="row align-items-center">
        <div class="col-lg-4 order-lg-2">
          <div class="p-0 m-0" style="text-align:center">
            <h3 class="text-center text-white keynote">CONFIRMED SPEAKER</h3>
            <p></p>
            <a href="img/salgado.png" target="_blank">
            <img class="img-fluid rounded-circle" src="img/rafaela.jpg" alt="">
            </a>
            <p></p>
            <h5 class="text-center text-white">Rafaela Salgado</h5>
            <h6 class="text-center text-white">Universidade Federal de Minas Gerais, Brazil</h6>
            <h6 class="text-center text-white">Associate Professor - ICB</h6>
          </div>
        </div>
        <div class="col-lg-8 order-lg-1">
          <div class="bg-faded p-4 intro-text ml-auto rounded">
            <h5 class="text-center bold">Targeting proteases to treat neglected and emerging diseases</h5>
            <p></p>
            <p class="mb-3" align="justify"> R. Salgado is Ph.D. in Chemistry and Biological Chemistry from University of California San Francisco, USA. Since 2011, she is affiliated to the Department of Biochemistry and Immunology at UFMG, where she applies computational techniques and experimental assays to development of new ligands and therapeutic targets. Recently, she was awarded with the prizes: “L’Oréal-UNESCO-ABC Para Mulheres na Ciência 2017, Categoria Química” and “L’Oréal-UNESCO For Women in Science International Rising Talent 2018”.
            </p>
          </div>
        </div>
      </div>
    </div>
  </section>

  <section class="page-section cta">
		<div id="daniele" class="container">
			<div class="row align-items-center">
				<div class="col-lg-4 order-lg-1">
					<div class="p-0 m-0" style="text-align:center">
            <h3 class="text-center text-white keynote">CONFIRMED SPEAKER</h3>
            <p></p>
            <a href="img/dparisi.png" target="_blank">
						<img class="img-fluid rounded-circle" src="img/parisi.jpg" alt="">
            </a>
            <p></p>
            <h5 class="text-center text-white">Daniele Parisi</h5>
            <h6 class="text-center text-white">Yale School of Medicine, USA</h6>
            <h6 class="text-center text-white">Postdoctoral Associate - Immunobiology</h6>
					</div>
				</div>
				<div class="col-lg-8 order-lg-2">
					<div class="bg-faded p-4 intro-text ml-auto rounded">
            <h5 class="text-center bold">Data fusion in drug-target interaction prediction for drug repositioning</h5>
            <p></p>
						<p class="mb-3" align="justify">    Identifying drug-target interactions is a crucial step in drug repositioning, the process of suggesting new indications for known drugs. There are about 9000 FDA-approved and experimental small molecule drugs and more than 500.000 protein records available. Performing in vitro experiments would be too expensive and time-consuming to check all the putative drug-target couples, therefore computational techniques might help to predict compound biological activity (IC50) and suggest new putative medical indications for existing drugs. Machine learning techniques such as Bayesian matrix factorization and deep neural networks can integrate structural information of drugs, proteins and their binding to better predict biological activity and suggest new drug-target interactions, with a big impact on the drug discovery process. Different kinds of side information can be used to help the prediction process, such as chemical structures of the drugs, 3D structures of the protein targets or phenotypic effect of drug-target interactions.
            In my work I analysed the contribution brought by different kinds of heterogeneous information in the prediction process, taking into account different modalities of validation, as well as advantages and difficulties related to the application of each specific type of data.
						</p>
					</div>
				</div>
			</div>
		</div>
	</section>

  <footer class="footer text-faded text-center py-5">
    <div class="container">
      <div class="row justify-content-left">
        <div class="col-lg-1 col-md-12 col-xs-12" style="text-align: left;">
          <h3 class="my-4 text-footer-title" style="text-align: center">Organization</h3>
          <div style="text-align: center">
            <a href="http://rsg-brazil.iscbsc.org/" target="_blank">
              <img class="img-fluid" style="width: 120px" src="img/rsg.png" alt="">
            </a>
          </div>
        </div>
        <div class="col-lg-11 col-md-12 col-xs-12" style="text-align: left;">
          <h3 class="my-4 text-footer-title" style="text-align: center">Support</h3>
          <div  style="text-align: center">
            <div style="display: inline;">
              <a href="https://pgbcs.ioc.fiocruz.br/" target="_blank">
                <img class="img-fluid" style="height: 100px" src="img/bcs.png" alt="">
              </a>
            </div>
            <div style="display: inline;">
              <a href="http://www.fiocruz.br/ioc/cgi/cgilua.exe/sys/start.htm?tpl=home" target="_blank">
                <img class="img-fluid" style="height: 80px" src="img/ioc.png" alt="">
              </a>
            </div>
            <div style="display: inline;">
              <a href="https://portal.fiocruz.br/" target="_blank">
                <img class="img-fluid" style="height: 80px" src="img/fiocruz.png" alt="">
              </a>
            </div>
            <div style="display: inline;">
              <a href="https://www.iscbsc.org/" target="_blank">
                <img class="img-fluid" style="height: 70px" src="img/ISCBSC.png" alt="">
              </a>
            </div>
            <div style="display: inline;">
              <a href="https://www.ab3c.org.br/site/" target="_blank">
                <img class="img-fluid" style="height: 50px" src="img/AB3C.png" alt="">
              </a>
            </div>
          </div>
        </div>
      </div>
      <p class="m-0 text-footer-small" style="padding-top: 20px;">Copyright © SIG:DRUG-DESIGN 2020</p>
    </div>
  </footer>

  <!-- Bootstrap core JavaScript -->
  <script src="vendor/jquery/jquery.min.js"></script>
  <script src="vendor/bootstrap/js/bootstrap.bundle.min.js"></script>

</body>

</html>
